Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Orion Oyj's share price for the quarter that ended in Mar. 2026 was $78.95. Orion Oyj's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 141 Mil. Therefore, Orion Oyj's market cap for the quarter that ended in Mar. 2026 was $11,121 Mil.
Orion Oyj's quarterly market cap
stayed the same
from Sep. 2025 ($11,438 Mil) to Dec. 2025 ($11,438 Mil) but then
declined
from Dec. 2025 ($11,438 Mil) to Mar. 2026 ($11,121 Mil).
Orion Oyj's annual market cap
increased
from Dec. 2023 ($5,387 Mil) to Dec. 2024 ($6,835 Mil) and
increased
from Dec. 2024 ($6,835 Mil) to Dec. 2025 ($11,438 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Orion Oyj's Enterprise Value for Today is $11,382 Mil.
Orion Oyj (OTCPK:ORINF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Orion Oyj Market Cap Related Terms
Orion Oyj Market Cap Historical Data
* Premium members only.
The historical data trend for Orion Oyj's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Orion Oyj's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Oyj Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's Market Cap distribution charts can be found below:
* The bar in red indicates where Orion Oyj's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Orion Oyj's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Oyj (ORINF) has a Market Cap of $11,234 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Orion Oyj and its competitors. According to the industry distribution chart, Orion Oyj ranks #48 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 4.7%.
Is Orion Oyj's Market Cap too high?
Orion Oyj's current Market Cap is $11,234 Mil. The Drug Manufacturers industry median Market Cap is 205.37. Orion Oyj's value of $11,234 Mil is 5370.1% above this industry median. Based on the distribution chart, Orion Oyj ranks #48 out of 1023 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Orion Oyj has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's Market Cap compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Orion Oyj ranks #48 out of 1023 companies for Market Cap. This places Orion Oyj in the top 5% of its industry — outperforming the majority of peers. The industry median Market Cap is 205.37. Orion Oyj's value of $11,234 Mil is 5370.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 205.37, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Oyj's current Market Cap of $11,234 Mil is 5370.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Orion Oyj and its competitors. For the Drug Manufacturers industry, the median Market Cap is 205.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Oyj's current Market Cap is $11,234 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Orion Oyj (ORINF) has a current Market Cap of $11,234 Mil. The stock's GF Value™ is $86.78, compared to a current price of $82.75 — trading 4.6% below its estimated fair value. The current Market Cap is $11,234 Mil and 5370.1% above the Drug Manufacturers industry median of 205.37. Orion Oyj's overall GF Score™ is 100/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Orion Oyj (ORINF), the current Market Cap is $11,234 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Oyj (ORINF) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Oyj stock appears to be undervalued.
The current stock price of $82.75 is trading 4.6% below its estimated GF Value™ of $86.78.
Key valuation signals for ORINF:
Market Cap: $11,234 Mil
GF Value™: $86.78 vs. price of $82.75 (4.6% below fair value)
Industry Position: 5370.1% above the Drug Manufacturers median (#48 of 1023)
No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
100GF Score
Get the complete analysis for ORINF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORINF has been successfully added to your 
